One of Trump's demands was that the CEOs' companies limit drug costs for states' Medicaid plans to "most-favored nation" ...

Learn how dentists treat gum disease with deep cleanings, antibiotics, and long-term care to protect your smile and overall ...

For outsourcing and manufacturing professionals, 2024 may be remembered as the year capacity and partnerships took center ...

The money will support dozens of different approaches for improving women’s health, from new medicines to prevent maternal ...

The prime minister fled. There's an interim government. Our writer urges global health groups, including WHO and UNICEF, to ...

Congress delegates heard how exciting developments in Parkinson’s disease research is aiding our understanding of this ...

Eli Lilly (NYSE: LLY) has been a terrific investment in recent years. Thanks to significant clinical progress and outstanding ...

Research and development (R&D) expenses were $49.5 million for the second quarter of 2025, compared to $49.9 million for the comparable period in 2024. The decrease was primarily related to the ...

Double-digit prescription gains for its commercial drugs, major coverage wins, and the early launch of a new migraine therapy were the most significant highlights. Despite substantial progress, the ...

Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall ...

The US pharmaceutical giant has already hired 100 professionals and plans to expand its headcount to 1,500 in the coming ...

Scientists from UC San Francisco and the Gladstone Institutes have made a discovery that could offer new hope to people with ...